Caitlin Hester, MD

Caitlin Hester, MD, a Complex General Surgical Oncology Fellow at MD Anderson, dives into the complexities of managing borderline resectable pancreatic cancer. She explains the definitions of resectability and the role of neoadjuvant therapy in optimizing patient outcomes. Insightful discussions cover key clinical trials, imaging biomarkers, and the surgical implications of vascular involvement. Hester also highlights future directions in research, including ctDNA and potential vaccines, fostering hope for better treatment strategies in this challenging field.